Follica Inc

Synthace Limited, based in Boston, MA, specializes in enhancing drug discovery processes through innovative software and expert support. With over 20 years of experience, their team focuses on streamlining experimental methods in assay development, media optimization, and purification process development. The company offers tailored solutions that empower scientists to adopt multifactorial methods and automation, significantly reducing the time required to gain insights. By integrating their software with existing lab resources, Synthace enables teams to achieve faster, more reliable results while fostering a culture of self-sufficiency in research practices. Generated from the website

Dropgenie, Inc., based in Boston, MA, is dedicated to accelerating the pace of drug discovery by enhancing the clinical relevance of research workflows. The company achieves this through innovative tools that leverage miniaturization and parallelization, resulting in significant reductions in input material, time, and cost. Founded by a team of experts, including co-founders Alison Hirukawa and Hugo Sinha, Dropgenie offers advanced lab automation solutions designed to integrate seamlessly with existing systems. Their first module enables gentle non-viral transfection in droplets, facilitating arrayed CRISPR screening at single-donor resolution. Generated from the website

Karuna Therapeutics is a Boston-based biopharmaceutical company focused on developing transformative medicines for individuals with psychiatric and neurological conditions. Powered by their expertise in drug mechanisms, they are dedicated to discovering and delivering innovative treatments that can significantly improve the lives of those affected by mental health disorders. Driven by a purpose to make a difference, Karuna Therapeutics is a team of compassionate and intentional innovators who strive to advance the field of psychiatric medicine. With a deep understanding of the needs of patients, they are committed to developing therapies that address the unmet medical needs in conditions such as schizophrenia and psychosis in Alzheimer's disease.Generated from the website